Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDRT15 pseudogene 12 (CDRT15P12)
- Target
- CDRT15P12
- Molecular classification
- Other, Pseudogene (processed/unprocessed, as per genomic classification)
01
Overview
CDRT15 pseudogene 12 (CDRT15P12) is a pseudogene located in the chromosome 17p12 region, which is known for being prone to genomic rearrangements such as the CMT1A duplication and HNPP deletion. While its parent gene, CDRT15, may be transcribed as part of an evolutionarily new gene family, the pseudogene variants, including CDRT15P12, are not known to produce functional proteins. There is currently no evidence for a disease association, biomarker use, or drug interaction related to this specific pseudogene, and it is not recognized as a therapeutic target.
- Other names
- CDRT15P12CMT1A Duplicated Region Transcript 15 Pseudogene 12
02
Mechanism of action
None. No mechanisms of action are described for drugs targeting this pseudogene.
03
Biological functions
None established for CDRT15P12 itself. Pseudogenes generally do not encode functional proteins, although some may have regulatory or minor roles, generally uncharacterized for this copy
04
Disease associations
Other (not directly implicated in disease; CDRT15 family is located in a genomic region associated with the CMT1A duplication/hereditary neuropathy with liability to pressure palsy (HNPP), but no evidence supports a disease-causing role for CDRT15P12 itself)
05
Safety considerations
None reported or anticipated for this pseudogene; it is not an active molecule or therapeutic target.
06
Interacting drugs
None. No known drugs interact with this pseudogene
07
Biomarkers
None established
Beyond the preview
Go deeper on CDRT15 pseudogene 12 (CDRT15P12).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CDRT15 pseudogene 12 (CDRT15P12).